丁香园论坛专题讨论
默克密理博官方微博中科院神经所王以政教授
中科院神经所王以政教授
Institute of Neuroscience, SIBS, CAS, Shanghai, China 200031
Brain injury after focal cerebral ischemia develops from a series of pathological processes. However, the results of clinical trials to prevent ischemic brain damage by blocking the detrimental effects are disappointing. We report that suppression of proteolytic degradation of transient receptor potential canonical (TRPC) 6 prevented ischemic neuronal cell death. The TRPC6 protein level in neurons was reduced in ischemia via N-methyl-D-aspartate (NMDA) receptor-dependent calpain proteolysis of N-terminal domain of TRPC6 at Lys16. A fusion peptide derived from the calpain cleavage site in TRPC6 inhibited its degradation, reduced infarct size and improved behavior outcome of ischemic rats. Thus, suppression of TRPC6 degradation prevented ischemic brain damage.
编辑: cq
以下网友留言只代表网友个人观点，不代表网站观点
